KLEANTHIS G XANTHOPOULOS Insider Trading $RGLS Regulus Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KLEANTHIS G XANTHOPOULOS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KLEANTHIS G XANTHOPOULOS. KLEANTHIS G XANTHOPOULOS is Director in APRICUS BIOSCIENCES, INC. ($APRI) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).

KLEANTHIS G XANTHOPOULOS in Regulus Therapeutics Inc.

Trading Symbol: RGLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KLEANTHIS G XANTHOPOULOS: President and CEO
Holdings: 3,705 shares
Current Value: $5,187
Latest Transaction: Apr 21 2015
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KLEANTHIS G XANTHOPOULOS in Regulus Therapeutics Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, RGLS, SEEL, ZSAN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3860,00022,8008,287
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3866,07125,10768,287
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3873,92928,093134,358
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS17.7360,0001,063,9803,70563.7 K to 3.7 K (-94.18 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3860,00022,80063,7053.7 K to 63.7 K (+1,619.43 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS16.8566,0711,113,5143,70569.8 K to 3.7 K (-94.69 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3866,07125,10769,7763.7 K to 69.8 K (+1,783.29 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS16.9473,9291,252,0023,70577.6 K to 3.7 K (-95.23 %)
Apr 21 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3873,92928,09377,6343.7 K to 77.6 K (+1,995.38 %)
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.3889,23033,907208,287
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS20.8123,616491,5512,46626.1 K to 2.5 K (-90.55 %)
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS20.0665,6141,316,51226,08291.7 K to 26.1 K (-71.56 %)
Mar 05 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3889,23033,90791,6962.5 K to 91.7 K (+3,618.41 %)
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOOption ExerciseM0.387027297,517
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOSellS19.50701,3652,4662.5 K to 2.5 K (-2.76 %)
Mar 03 2015RGLSRegulus Therapeuti ...XANTHOPOULOS KLEANTHIS GPresident and CEOBuyM0.3870272,5362.5 K to 2.5 K (+2.84 %)

Page:   1